Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo - PubMed (original) (raw)

Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo

A Lieber et al. J Virol. 1996 Dec.

Abstract

In vivo gene transfer of recombinant E1-deficient adenoviruses results in early and late viral gene expression that elicits a host immune response, limiting the duration of transgene expression and the use of adenoviruses for gene therapy. The prokaryotic Cre-lox P recombination system was adapted to generate recombinant adenoviruses with extended deletions in the viral genome (referred to here as deleted viruses) in order to minimize expression of immunogenic and/or cytotoxic viral proteins. As an example, an adenovirus with a 25-kb deletion that lacked E1, E2, E3, and late gene expression with viral titers similar to those achieved with first-generation vectors and less than 0.5% contamination with E1-deficient virus was produced. Gene transfer was similar in HeLa cells, mouse hepatoma cells, and primary mouse hepatocytes in vitro and in vivo as determined by measuring reporter gene expression and DNA transfer. However, transgene expression and deleted viral DNA concentrations were not stable and declined to undetectable levels much more rapidly than those found for first-generation vectors. Intravenous administration of deleted vectors in mice resulted in no hepatocellular injury relative to that seen with first-generation vectors. The mechanism for stability of first-generation adenovirus vectors (E1a deleted) appeared to be linked in part to their ability to replicate in transduced cells in vivo and in vitro. Furthermore, the deleted vectors were stabilized in the presence of undeleted first-generation adenovirus vectors. These results have important consequences for the development of these and other nonintegrating vectors for gene therapy.

PubMed Disclaimer

Cited by

Restricting expression prolongs expression of foreign genes introduced into animals by retroviruses.
Pinto VB, Prasad S, Yewdell J, Bennink J, Hughes SH. Pinto VB, et al. J Virol. 2000 Nov;74(21):10202-6. doi: 10.1128/jvi.74.21.10202-10206.2000. J Virol. 2000. PMID: 11024149 Free PMC article.
Episomal segregation of the adenovirus enhancer sequence by conditional genome rearrangement abrogates late viral gene expression.
Wang X, Zeng W, Murakawa M, Freeman MW, Seed B. Wang X, et al. J Virol. 2000 Dec;74(23):11296-303. doi: 10.1128/jvi.74.23.11296-11303.2000. J Virol. 2000. PMID: 11070029 Free PMC article.
Variables affecting in vivo performance of high-capacity adenovirus vectors.
Schiedner G, Hertel S, Johnston M, Biermann V, Dries V, Kochanek S. Schiedner G, et al. J Virol. 2002 Feb;76(4):1600-9. doi: 10.1128/jvi.76.4.1600-1609.2002. J Virol. 2002. PMID: 11799154 Free PMC article.
Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5.
Abe S, Okuda K, Ura T, Kondo A, Yoshida A, Yoshizaki S, Mizuguchi H, Klinman D, Shimada M. Abe S, et al. J Gene Med. 2009 Jul;11(7):570-9. doi: 10.1002/jgm.1332. J Gene Med. 2009. PMID: 19391169 Free PMC article.
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.
Nichols TC, Dillow AM, Franck HW, Merricks EP, Raymer RA, Bellinger DA, Arruda VR, High KA. Nichols TC, et al. ILAR J. 2009;50(2):144-67. doi: 10.1093/ilar.50.2.144. ILAR J. 2009. PMID: 19293459 Free PMC article. Review.

References

1. Biotechniques. 1996 Feb;20(2):278-85 - PubMed
1. J Virol. 1996 Oct;70(10):7030-8 - PubMed
1. Gene Ther. 1996 Jan;3(1):75-84 - PubMed
1. Virology. 1973 Jul;54(1):299-303 - PubMed
1. J Gen Virol. 1978 Jul;40(1):45-61 - PubMed

Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo - PubMed (original) (raw)